PulseAugur
EN
LIVE 01:42:41
中文(ZH) 南新制药：股票将被实施其他风险警示，明起停牌一天

Nanxin Pharma fined 11.5M yuan for disclosure violations; U.S. Steel invests $2.5B

By PulseAugur Editorial · [1 sources] ·

Nanxin Pharmaceutical has received an administrative penalty from the Hunan Securities Regulatory Bureau for alleged information disclosure violations. The company and its personnel face a total fine of 11.5 million yuan, and its stock will be suspended for one day before being subject to risk warnings. Separately, U.S. Steel announced plans to invest up to $2.5 billion in a new hot-rolled coil plant in Pennsylvania. AI

RANK_REASON The cluster contains a significant regulatory action against a company and a major capital investment announcement. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Nanxin Pharma fined 11.5M yuan for disclosure violations; U.S. Steel invests $2.5B

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
The cluster contains a significant regulatory action against a company and a major capital investment announcement. [lever_c_demoted from significant: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, funding
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
109 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Nanxin Pharmaceutical: Stock to be subject to other risk warnings, trading suspended for one day starting tomorrow

    36氪获悉，南新制药公告，公司收到湖南证监局出具的《行政处罚事先告知书》，公司及相关人员涉嫌信息披露违法违规行为已调查完毕，湖南证监局拟决定对公司给予警告，并处以500万元罚款；对相关人员给予警告，并处以共650万元罚款。根据相关规定，股票6月10日停牌，6月11日起将被实施其他风险警示，实施后A股简称为ST南新。

RELATED TOPICS